Who owns TAYSHA GENE THERAPIES INC?
- Ticker: TSHA
- CUSIP Number: 877619106
Tip: Access positions for across all investors
Analyze quarterly positions in Taysha Gene Therapies with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Taysha Gene Therapies stock
Who bought or sold TAYSHA GENE THERAPIES INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
RA Capital Management | 19M | $33M | 0% | Dec 2023 |
|
VR Adviser | 10M | $18M | -28% | Dec 2023 |
|
Vanguard Group | 6.2M | $11M | 16% | Dec 2023 |
|
venBio Select Advisor | 4.4M | $7.7M | 11% | Dec 2023 |
|
Baker Bros. Advisors | 4.0M | $7.1M | 60% | Dec 2023 |
|
Artal Group | 3.7M | $6.5M | 0% | Dec 2023 |
|
Millennium Management | 3.4M | $6.1M | 6761% | Dec 2023 |
|
Point72 Asset Management | 2.7M | $4.8M | 187% | Dec 2023 |
|
Citadel Advisors | 2.3M | $4.1M | 3643% | Dec 2023 |
|
T. Rowe Price Associates | 1.2M | $2.2M | -2% | Dec 2023 |
|
Schonfeld Strategic Advisors | 1.1M | $2.0M | 55% | Dec 2023 |
|
Exome Asset Management | 693k | $1.2M | 100% | Dec 2023 |
|
Alphabet | 641k | $1.1M | 0% | Dec 2023 |
|
Quantum Private Wealth | 640k | $1.1M | 11% | Dec 2023 |
|
Palo Alto Investors | 530k | $938k | 100% | Dec 2023 |
|
Citigroup | 311k | $550k | 11% | Dec 2023 |
|
Monaco Asset Management SAM | 295k | $522k | 100% | Dec 2023 |
|
Kovitz Investment Group Partners | 278k | $492k | 1011% | Dec 2023 |
|
ADAR1 Capital Management | 209k | $370k | 100% | Dec 2023 |
|
Polar Securities | 187k | $331k | 100% | Dec 2023 |
|
TD Asset Management | 176k | $311k | 0% | Dec 2023 |
|
Two Sigma Investments | 137k | $242k | 100% | Dec 2023 |
|
Chicago Partners Investment | 135k | $198k | 21% | Dec 2023 |
|
Bank of America Corporation | 122k | $217k | 220% | Dec 2023 |
|
Goldman Sachs Group | 84k | $148k | 100% | Dec 2023 |
|
Squarepoint Ops | 64k | $112k | 122% | Dec 2023 |
|
Bank of New York Mellon | 58k | $103k | 123% | Dec 2023 |
|
Cubist Systematic Strategies | 48k | $86k | 100% | Dec 2023 |
|
Dynamic Advisors Solutions | 45k | $129k | 0% | Mar 2024 |
|
Williams & Novak | 45k | $80k | 0% | Mar 2024 |
|
Redwood Wealth Management Group | 43k | $75k | 12% | Dec 2023 |
|
Jane Street | 42k | $75k | 100% | Dec 2023 |
|
Jpmorgan Chase & Co | 37k | $65k | 26531% | Dec 2023 |
|
Connor, Clark & Lunn Investment Management | 35k | $63k | 100% | Dec 2023 |
|
Graham Capital Management | 29k | $50k | 100% | Dec 2023 |
|
Commonwealth Equity Services | 27k | $47k | -1% | Dec 2023 |
|
Virtu Financial | 26k | $46k | 100% | Dec 2023 |
|
Cannon Global Investment Management | 24k | $70k | 100% | Mar 2024 |
|
China Universal Asset Management | 22k | $38k | 100% | Dec 2023 |
|
Lee Financial | 20k | $35k | 0% | Dec 2023 |
|
Dynamic Technology Lab Private | 17k | $31k | 100% | Dec 2023 |
|
Two Sigma Securities | 17k | $30k | -38% | Dec 2023 |
|
Charles Schwab Investment Management | 16k | $29k | 0% | Dec 2023 |
|
Victory Capital Management | 16k | $28k | 100% | Dec 2023 |
|
Howard Capital Management | 14k | $25k | 100% | Dec 2023 |
|
Darren Munn | 11k | $20k | 100% | Dec 2023 |
|
Royal Capital Wealth Management | 11k | $19k | 100% | Dec 2023 |
|
Capital Investment Advisors | 10k | $29k | 0% | Mar 2024 |
|
Lazard Asset Management | 8.8k | $0 | 100% | Dec 2023 |
|
Quarry | 8.0k | $14k | 100% | Dec 2023 |
|
Wells Fargo & Company | 7.4k | $13k | 14% | Dec 2023 |
|
UBS Group | 3.9k | $7.0k | 617% | Dec 2023 |
|
Hanson McClain Advisors | 1.0k | $1.8k | 0% | Dec 2023 |
|
Morton Brown Family Wealth | 260.00 | $459.992000 | 100% | Dec 2023 |
|
Advisor Group Holdings | 134.00 | $237.997400 | 0% | Dec 2023 |
|
Capital Advisors | 79.00 | $0 | 0% | Mar 2024 |
|
Signature | 50.00 | $89.000000 | 100% | Dec 2023 |
|
Who sold out of Taysha Gene Therapies?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Kynam Capital Management | Sep 2023 | 3.3M | $10M |
Octagon Capital Advisors | Sep 2023 | 2.8M | $8.8M |
Franklin Resources | Sep 2023 | 811k | $2.6M |
Simplex Trading | Sep 2023 | 15k | $46k |